About 100 reports

COMPANY) Valeant Pharmaceuticals International, Inc. is a multinational pharmaceutical company that develops, manufactures, and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, ophthalmology, and neurology and consumer healt

  • Eye Disease
  • Abbott Medical Optics, Inc.
  • Alcon, Inc.
  • Bausch & Lomb Incorporated
  • Carl Zeiss Meditec AG

gastrointestinal, central nervous system, and hormonal therapies).

  • Eye Disease
  • World
  • CooperVision, Inc.
  • Novartis AG
  • Valeant Pharmaceuticals International, Inc.
  • Eye Disease
  • World
  • Adverum Biotechnologies, Inc.
  • Alcon, Inc.
  • Allergan plc
  • Global ophthalmology surgical devices market segmentation

Ophthalmology procedures account for about ##% of the total surgeries performed at surgical centers, just after gastrointestinal and endoscopy procedures at ##%.

  • Eye Disease
  • Abbott Medical Optics, Inc.
  • Alcon, Inc.
  • Bausch & Lomb Incorporated
  • Carl Zeiss AG

Various human tissue types such as prostate, breast, lung, colon, and gastrointestinal tissues are studied by using the optical biopsy method.

  • Eye Disease
  • Alcon, Inc.
  • IRIDEX Corporation
  • Lumenis Ltd.
  • Syneron Medical Ltd.

gastrointestinal, central nervous system, and hormonal therapies).

  • Eye Disease
  • Alcon, Inc.
  • Essilor group
  • Luxottica Group
  • Novartis AG
  • Strengths

The combined brand portfolio of Actavis and Allergan includes medication in key therapeutic categories such as dermatology, CNS, eye care, women' s health, urology, gastrointestinal, cystic fibrosis, cardiovascular, and infectious diseases.

  • Anti-Infective
  • Eye Disease
  • Akorn, Inc.
  • Alcon, Inc.
  • Allergan plc
  • Eye Disease
  • North America
  • United States
  • Circassia Pharmaceuticals plc
  • RXi Pharmaceuticals Corporation

The Actavis and Allergan combined brand portfolio includes drugs in key therapeutic categories such as dermatology, central nervous system (CNS), eye care, women' s health, urology, gastrointestinal, cystic fibrosis, cardiovascular, and infectious diseases.

  • Eye Disease
  • Forecast
  • Alcon, Inc.
  • Allergan plc
  • Otsuka Pharmaceutical Co., Ltd.

gastrointestinal, central nervous system, and hormonal therapies).

  • Eye Disease
  • World
  • Forecast
  • Novartis AG
  • Valeant Pharmaceuticals International, Inc.

gastrointestinal pain, and hormonal therapies among others).

  • Eye Disease
  • Forecast
  • Novartis AG
  • The Cooper Companies, Inc.
  • Valeant Pharmaceuticals International, Inc.

TEAR FILM MUCINS: FRONT LINE DEFENDERS OF THE OCULAR SURFACE; COMPARISON WITH AIRWAY AND GASTROINTESTINAL TRACT MUCINS.

  • Eye Disease
  • Allergan plc
  • Herantis Pharma Plc
  • RegeneRx Biopharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.

/ Ocriplasmin ## g Placebo ##/ ##(##. ##%) Total, serious adverse events Cardiac disorders Cardiac failure congestive Eye disorders Macular hole Retinal detachment Maculopathy Visual acuity reduced Gastrointestinal disorders Small intestinal obstruction Upper

  • Eye Disease
  • Therapy
  • United States
  • World
  • ThromboGenics NV

gastrointestinal neuroendocrine tumors/ carcinoid (GI-NET).

  • Eye Disease
  • World
  • Bayer AG
  • Lpath, Inc.
  • OXiGENE, Inc.

GASTROINTESTINAL TRACT, CERVICAL CANCER, MALIGNANT PLEURAL MESOTHELIOMA AND LOCALLY ADVANCED AND/ OR METASTATIC PANCREATIC CANCER.

  • Eye Disease
  • World
  • Bayer AG
  • Novartis AG
  • Regeneron Pharmaceuticals, Inc.

TEAR FILM MUCINS: FRONT LINE DEFENDERS OF THE OCULAR SURFACE; COMPARISON WITH AIRWAY AND GASTROINTESTINAL TRACT MUCINS.

  • Eye Disease
  • Allergan plc
  • Mimetogen Pharmaceuticals Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • Santen Pharmaceutical Co., Ltd.
  • 21.2 Market Share Analysis 2014

The combined portfolio of the two companies includes drugs in areas of dermatology, CNS, eye care, women' s health, urology, gastrointestinal, cystic fibrosis, cardiovascular, and infectious diseases.

  • Eye Disease
  • Actavis plc
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co., Inc.
  • Novartis AG

Tear film mucins: front line defenders of the ocular surface; comparison with airway and gastrointestinal tract mucins.

  • Eye Disease
  • Allergan plc
  • Mitotech S.A.
  • RegeneRx Biopharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.

CURRENTLY, THIS INTUITIVE TECHNOLOGY IS BEING APPLIED IN THE FIELD OF GASTROINTESTINAL, THORACIC, GYNECOLOGICAL, AND UROLOGICAL SURGERIES.

  • Eye Disease
  • Hospital
  • Surgery
  • Asia
  • Forecast

Tear film mucins: front line defenders of the ocular surface; comparison with airway and gastrointestinal tract mucins.

  • Eye Disease
  • Allergan plc
  • Mitotech S.A.
  • RegeneRx Biopharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.

Tear film mucins: front line defenders of the ocular surface; comparison with airway and gastrointestinal tract mucins.

  • Eye Disease
  • Allergan plc
  • Mitotech S.A.
  • RegeneRx Biopharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.

The company' s major therapeutic areas include immunology, CVD, diabetes, gastrointestinal (GI) disease, infectious diseases, musculoskeletal disease, neuroscience, oncology, ophthalmology, and respiratory diseases.

  • Eye Disease
  • Europe
  • Demand
  • Market Size
  • Acucela Inc.

Tear film mucins: front line defenders of the ocular surface; comparison with airway and gastrointestinal tract mucins.

  • Eye Disease
  • Allergan plc
  • Mitotech S.A.
  • RegeneRx Biopharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.

Tear film mucins: front line defenders of the ocular surface; comparison with airway and gastrointestinal tract mucins.

  • Eye Disease
  • Allergan plc
  • Mitotech S.A.
  • RegeneRx Biopharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.

Indications for a colectomy or colon resection include colon cancer, diverticular disease, gastrointestinal bleeding, inflammatory bowel disease (including colitis and Crohn' s disease), intestinal polyps, and large bowel obstruction.

  • Eye Disease
  • Healthcare
  • Hospital
  • Europe
  • Forecast

gastrointestinal th Appendix Medicines and Healthcare products Regulatory Agency macular edema following central retinal vein occlusion macular edema following branch retinal vein occlusion Novartis Institutes for BioMedical Research National Health Service New Drug Application Macular Dege

  • Eye Disease
  • Europe
  • Allergan plc
  • Novartis AG
  • Regeneron Pharmaceuticals, Inc.

The company' s major therapeutic areas include immunology, CVD, diabetes, gastrointestinal (GI) disease, infectious diseases, musculoskeletal disease, neuroscience, oncology, ophthalmology, and respiratory diseases.

  • Eye Disease
  • Acucela Inc.
  • Alimera Sciences, Inc.
  • Allergan plc
  • Ampio Pharmaceuticals, Inc.
  • 2. INTRODUCTION

CMV INFECTION CAN OCCUR IN SEVERAL PARTS OF THE BODY (SUCH AS GASTROINTESTINAL SYSTEM, RETINA) AND CAN SPREAD THROUGH THE BLOODSTREAM.

  • Eye Disease
  • United States
  • Allergan plc
  • Neurotech Pharmaceuticals, Inc.
  • pSivida Corp.

gastrointestinal geographic atrophy fundus autofluorescence fluorescein angiogram eicosapentaenoic acid diabetic macular edema docosahexaenoic acid cardiovascular disease central retinal thickness CFT: CME: CMT: CNV: CRT: CRVO: CSME: CVD: dAMD: DHA: DME: DOG: DRCR: EPA: EphMRA: ETDRS: EuRet

  • Eye Disease
  • Ophthalmology
  • Therapy
  • United States
  • Regeneron Pharmaceuticals, Inc.

gastrointestinal geographic atrophy US Food and Drug Administration fundus autofluorescence fluorescein angiogram eicosapentaenoic acid German Ophthalmological Society diabetic macular edema CRVO: CSME: CVD: dAMD: DME: DOG: DRCR: EPA: EphMRA: ETDRS: EuRetina: FA: FAF: FDA: GA: GI: GP: HOME:

  • Eye Disease
  • Ophthalmology
  • Pathology
  • Therapy
  • Santen Pharmaceutical Co., Ltd.